Key result
Amicheck-Trop showed higher sensitivity (~80% vs ~20%) and a lower limit of detection (0.3-0.4 vs 1.8-2.0 ng/ml) for cardiac troponin I compared to three other rapid immunochromatographic tests.
Why the study?
What is the diagnostic performance and limit of detection of four rapid immunochromatographic tests for cardiac troponin I in a resource-limited setting?
Observational
What is the diagnostic performance and limit of detection of four rapid immunochromatographic tests for cardiac troponin I in a resource-limited setting?
Absolute Event Rate: 80% vs 20%
Amicheck-Trop provides superior sensitivity and a lower limit of detection compared to other rapid troponin tests, making it potentially useful for diagnosing acute myocardial infarction in resource-limited settings.
Cardiac troponin I (cTnI) is a sensitive and specific marker of acute coronary syndromes and myocardial damage. During the past few years, it has become the preferred biochemical marker of myocardial infarction. However, due to the sensitivity required for its detection, only automated systems can be used in developed countries. However, these are rather expensive and unaffordable for most laboratories in developing countries. Many manufacturers have therefore proposed rapid immunochromatographic tests to detect cTnI. The aim of this study was to assess the limit of detection (LOD) and performance of four rapid immunochromatographic tests available in Madagascar. The four tests evaluated were Hexagon Troponin, Nadal troponin I cassette, Troponitest+, and Amicheck-Trop. Amicheck-Trop had a sensitivity and negative predictive value of about 80%, whereas for the three others, they were about 20%. The specificity of Amicheck-Trop of 87.3% was lower than the specificities of the other tests (98% to 100%). These differences were explained by the limits of detection of the tests: 0.3 to 0.4 ng/ml for Amicheck-Trop but only 1.8 to 2 ng/ml for the three other tests. It was concluded that Amicheck-Trop could be useful in the management of acute myocardial infarction or myocarditis in sparsely equipped laboratories in developing countries.
No takes yet. Share an insight, caveat, or question.
Ramparany et al. (2011) conducted an observational in Acute myocardial infarction or myocarditis. Amicheck-Trop rapid immunochromatographic test vs. Hexagon Troponin, Nadal troponin I cassette, and Troponitest+ was evaluated on Sensitivity for detecting cardiac troponin I. Amicheck-Trop showed higher sensitivity (~80% vs ~20%) and a lower limit of detection (0.3-0.4 vs 1.8-2.0 ng/ml) for cardiac troponin I compared to three other rapid immunochromatographic tests.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: